Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by saveyourselfnowon Jul 22, 2018 4:29pm
243 Views
Post# 28350605

RE:RE:All these LPs are worth half of current market cap..

RE:RE:All these LPs are worth half of current market cap..
Easymoney123 wrote: ACB is being valued on forward earnings.  This company is not being valued for what it can do today but rather what it will be able to do after Oct 17.  I don’t understand why people keep bringing up its valuation right now?  The market is predicting big time earnings for companies like ACB once legalization happens.  570,000 kg at today’s prices would equal almost 4.6 billion in revenue just on dried cannabis.  ACB averages 8 dollars a gram right now.   ACB will also have 72,000 litres of oils from Cannimed valued around 1.5 billion.  You do the math you really think 700 million will be hard for this company to achieve?  If your valuation of 10 times yearly revenue then once ACB Is at full capacity they could earn 6 billion plus a year so they would have a 60 billion market cap.  Let’s not even talk about what happens if Germany eventually legalizes Rec or England legalizes medicinal?  The opportunities are just getting started.


The bots dine on the minute.
You advise to dine on the year.
Buy and Hold strategies have been obliterated since Jan 2018.

Too many people were late for the party and the are, categorically, bag holders going forward.

Cash is King, there WILL be better buying opportunites.
Bullboard Posts